NBI Development, a San Francisco medical device company focused on neuro-modulation therapies, has raised $5.5 million in first-round funding, according to PE Wire. Three Arch Partners and Bay City Capital co-led the deal, and were joined by MPM Capital, Aberdare Ventures, Mayo Clinic and the Venturi Group.

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn more about membership.